| Canagliflozin and renal outcomes in type 2 diabetes and nephropathy V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ... N Engl J Med, 2019 | 4550 | 2019 |
| The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo … C Baigent, MJ Landray, C Reith, J Emberson, DC Wheeler, C Tomson, ... The Lancet 377 (9784), 2181-2192, 2011 | 2836 | 2011 |
| A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease MA Pfeffer, EA Burdmann, CY Chen, ME Cooper, D De Zeeuw, ... New England Journal of Medicine 361 (21), 2019-2032, 2009 | 2349 | 2009 |
| Rosuvastatin and cardiovascular events in patients undergoing hemodialysis BC Fellström, AG Jardine, RE Schmieder, H Holdaas, K Bannister, ... New England Journal of Medicine 360 (14), 1395-1407, 2009 | 2227 | 2009 |
| Peritoneal dialysis-related infections recommendations: 2010 update PKT Li, CC Szeto, B Piraino, J Bernardini, AE Figueiredo, A Gupta, ... Peritoneal Dialysis International 30 (4), 393-423, 2010 | 1237 | 2010 |
| ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. L Philip, CC Szeto, B Piraino, J de Arteaga, S Fan, A Figueiredo, D Fish, ... Perit Dial Int 36 (5), 481-508, 2016 | 1086 | 2016 |
| A randomized, controlled trial of early versus late initiation of dialysis BA Cooper, P Branley, L Bulfone, JF Collins, JC Craig, MB Fraenkel, ... New England Journal of Medicine 363 (7), 609-619, 2010 | 985 | 2010 |
| Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy A Levin, M Tonelli, J Bonventre, J Coresh, JA Donner, AB Fogo, CS Fox, ... The Lancet 390 (10105), 1888-1917, 2017 | 851 | 2017 |
| Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies S Palmer, M Vecchio, JC Craig, M Tonelli, DW Johnson, A Nicolucci, ... Kidney international 84 (1), 179-191, 2013 | 832 | 2013 |
| Oxidative stress, anti‐oxidant therapies and chronic kidney disease DM Small, JS Coombes, N Bennett, DW Johnson, GC Gobe Nephrology 17 (4), 311-321, 2012 | 594 | 2012 |
| Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials GFM Strippoli, SD Navaneethan, DW Johnson, V Perkovic, F Pellegrini, ... Bmj 336 (7645), 645-651, 2008 | 531 | 2008 |
| HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. SD Navaneethan, F Pansini, V Perkovic, C Manno, F Pellegrini, ... The Cochrane database of systematic reviews, CD007784-CD007784, 2009 | 503* | 2009 |
| Changes in the worldwide epidemiology of peritoneal dialysis PKT Li, KM Chow, MWM Van de Luijtgaarden, DW Johnson, KJ Jager, ... Nature Reviews Nephrology 13 (2), 90-103, 2017 | 500 | 2017 |
| The current state of peritoneal dialysis R Mehrotra, O Devuyst, SJ Davies, DW Johnson Journal of the American Society of Nephrology: JASN 27 (11), 3238, 2016 | 488 | 2016 |
| Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis SC Palmer, D Mavridis, A Nicolucci, DW Johnson, M Tonelli, JC Craig, ... Jama 316 (3), 313-324, 2016 | 462 | 2016 |
| Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease SC Palmer, SD Navaneethan, JC Craig, DW Johnson, M Tonelli, AX Garg, ... Annals of internal medicine 153 (1), 23-33, 2010 | 457 | 2010 |
| Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial J Lv, H Zhang, MG Wong, MJ Jardine, M Hladunewich, V Jha, ... Jama 318 (5), 432-442, 2017 | 438 | 2017 |
| Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta … SC Palmer, B Tendal, RA Mustafa, PO Vandvik, S Li, Q Hao, D Tunnicliffe, ... Bmj 372, 2021 | 436 | 2021 |
| ISPD position statement on reducing the risks of peritoneal dialysis–related infections B Piraino, J Bernardini, E Brown, A Figueiredo, DW Johnson, WC Lye, ... Peritoneal Dialysis International 31 (6), 614-630, 2011 | 419 | 2011 |
| Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease Sharp Collaborative Group American heart journal 160 (5), 785-794. e10, 2010 | 411 | 2010 |
Carmel HawleyUniversity of QueenslandVerified email at health.qld.gov.au
